Bioprocessing news: Sartorius cites single use as growth driver

Sartorius has attributed double-digit growth figures in 2014 to increased demand across the US for single use technologies.

The firm posted a 32% growth in sales across the region. For the full year, the international laboratory and process technology company reported sales across its business of 891 million Euros ($1.01bm). This is up 13% on 2013.
Sartorius’ bioprocess solutions division, which provides technologies and services to the biomanufacturing industry, generated 70% of the total revenues.
Group CEO, Joachim Kreuzburg, said “overall” 2014 had proved to be a “highly successful year” for the firm.
“Our largest divisions, Bioprocess Solutions,” he added, “reported double-digit gains for the fourth year in succession and again proved to be the key growth driver for our company’s sales and earnings.
“The results for Lab Products & Services were still impacted by portfolio cleaning, as expected, but with the start of the new year, this is now behind us.”

Bioprocess solutions stimulating the growth

Inga Stucke, a spokesperson for Sartorius, said the growth had been led by its bioprocess solutions unit. “Demand for single use products was high across our entire product range,” Ms Stucke said in comments to Biopharma-Reporter.com. “It came from our fluid management products such as single use bags, filters and also from single use fermenters.”
For 2015, Ms Stucke predicted additional growth in its bioprocess division in the range of 5-8%.
In related news, Sartorius has just completed the sale of its Industrial Technologies Division to the Japanese Minebea Co Ltd.
The move is designed to free up more time and resources for Sartorius to direct towards bioprocessing and laboratory equipment.

Author

Phill Allen

Managing Director

Phill is an innovative thinker particularly in fluid management. His expertise lies in ensuring the seamless flow of pharmaceutical liquid logistics, whether it's optimising current processes or pioneering new approaches.

Follow me